Analyst Bullish on Cynosure (CYNO) Acquisition of PMTI (PMTI)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Maxim Group Downgrades Palomar Medical Technologies (PMTI) to Hold
March 19, 2013 9:16 AM EDTMaxim Group downgraded Palomar Medical Technologies (NASDAQ: PMTI) from Buy to Hold.
For an analyst ratings summary and ratings history on Palomar Medical Technologies click here. For more ratings news on Palomar Medical Technologies click here.
Shares of Palomar Medical Technologies closed at $13.17 yesterday, with a 52 week range of $7.06-$13.42.... More
Cynosure (CYNO) to Acquire Palomar Medical (PMTI) for $13.65/Share
March 18, 2013 7:25 AM EDTCynosure, Inc. (Nasdaq: CYNO) and Palomar Medical Technologies, Inc. (Nasdaq: PMTI) today announced that they have signed a definitive agreement, pursuant to which Cynosure will acquire Palomar in a cash and stock transaction valued at approximately $294 million.
Palomar shareholders will receive $13.65 per share of Palomar common stock: $6.825 per share in cash and $6.825 per share in Cynosure common stock (subject to adjustment and collar provisions described in the definitive agreement). Cynosure will issue approximately 5.2 million shares in the transaction and fund the approximately $147 million in cash... More
